A Study of Cariprazine in the Prevention of Relapse of Symptoms in Participants With Schizophrenia
Clinical trial NCT01412060 · COMPLETED
Trial details
- NCT number
- NCT01412060
- Sponsor
- Forest Laboratories
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-27
- Primary completion
- 2014-09-03
- Enrollment
- 765
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.